Each of the nanomaterials was tested at least twice, and all tests fulfilled test guideline validity criteria, i.e., (1) ≥30 juveniles must be produced in each of the replicate control vessels by the end of the test; (2) the reproductive coefficient of variation in the control vessels must be ≤30%; and (3) adult mortality in the control vessels over the initial 4 weeks of the test must be ≤10%.
Additionally, some of these families also fulfilled mutation testing criteria for other hereditary breast cancer syndromes, as described in the NCCN Practice Guidelines in Oncology – v.1.2010 [ 37].
Clinically, this family fulfilled genetic testing criteria for both hereditary breast and ovarian cancer (HBOC) and LFL (Eeles 1 criteria) syndromes; the cancer family history was significant for the presence of two individuals with multiple primary tumors, including the proband.
Due to the high frequency of breast and other cancers in LFS/LFL individuals, there may be an overlap of phenotypes, and often some families fulfill genetic testing criteria for more than one hereditary breast cancer syndrome [ 1, 8, 9].
Patients are required to fulfill the test criteria on the Hospital Anxiety and Depression Scale (HADS, depression score ≥8) and a diagnosis of a depressive disorder by the Structured Clinical Interview for DSM IV Disorders (SCID-I).
All children who fulfill the influenza testing criteria are scheduled for follow-up appointments, during which physicians complete an influenza follow-up form that collects information on illness duration and severity.
To further strengthen this point a representative curve of one child illustrating, a poor effort performed at teaching process vs. end of test curve is shown in figure 4. The poor-effort curve did not fulfill start of test criteria and is round while the "end of test curve" has an obstructed shape.
All parameters tested fulfilled the criteria for bioequivalence between treatments, and no pharmacokinetic interaction was observed between warfarin and rivaroxaban.
When the preliminary test fulfilled the criteria described above, leukapheresis was performed to isolate autologous peripheral blood mononuclear cells (PBMCs) and harvest plasma.
Overall 92% of the pre-bronchodilator spirometry tests fulfilled ATS criteria of quality in the three first sites (97% in Montevideo, 91% in Mexico and 89% in Sao Paulo).
In the present study, 25 out of 260 genes tested fulfilled these criteria and could be considered as potential immune-responsive genes.
